The Symplicity HTN-2 trial is an international, multi-center, prospective, randomized, controlled study of renal denervation in patients with treatment-resistant hypertension.

FORBES: Promising One Year Results For Renal Denervation In Resistant Hypertension Spark Hype

More information about HTN-3 can be found at www.symplifybptrial.com.

FORBES: About the Symplicity? Renal Denervation System